Temozolomide Should be Considered for Recurrent Ependymoma
Temozolomide should be considered as a possible first-line treatment for adults with intracranial ependymoma after failure of surgery and radiotherapy.
Diagnosis & Disease Information
Bevacizumab May Add Survival Benefit for Wild-type Proneural Glioblastoma
A retrospective analysis showed that first-line bevacizumab treatment may provide overall survival in glioblastoma.
Proton Therapy Well-Tolerated for Low-Grade Gliomas
Patients with low-grade glioma were found to tolerate proton radiation therapy without difficultly.
Bevacizumab-Induced Hypertension Indicative of Better Survival in Glioblastoma
Glioblastoma patients who developed bevacizumab-induced hypertension experienced increased survival.
Anticoagulation May Be Safe for Patients with Brain Metastases
Therapeutic anticoagulation is safe for treating venous thromboembolism in patients with cancer that has metastasized to the brain.
Efficacy of Chemotherapy Similar to Radiotherapy for Anaplastic Glioma
Long-term data do not support efficacy of primary temozolomide monotherapy versus radiotherapy in anapestic glioma.
Tumor Treating Fields Improve Survival in Newly Diagnosed Glioblastoma
Tumor Treating Fields improved progression-free survival and overall survival in patients with newly diagnosed glioblastoma.
Initial Radiosurgery Plus Close Monitoring Recommended for Newly Diagnosed Brain Metastases
Radiosurgery and close monitoring is recommended to better preserve cognitive function in newly diagnosed brain metastases.
Nivolumab Plus Ipilimumab Demonstrates Activity in Recurrent Glioblastoma
The adverse event profile of nivolumab with or without ipilimumab in patients with glioblastoma was encouraging.
Addition of Levetiracetam May Improve Survival for Glioblastoma
Levetiracetam may provide a survival benefit in patients with glioblastoma who receive temozolomide-based chemotherapy.
- Loading...
Loading...
Next post in Brain Cancer
Loading... 
Loading...